Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
Tamara Isermann(German Cancer Research Center), Ramona Schulz‐Heddergott(Universitätsmedizin Göttingen)
Cited by 1
Related Papers
Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer
|Cell Death and Disease|2021|109
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
|Cell Death and Differentiation|2025|9